Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sitagliptin Phosphate Monohydrate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117467733B reveals immobilized transaminase process for Sitagliptin. Achieve high optical purity and cost reduction in API manufacturing with scalable biocatalysis.
Patent CN113149991A details a safer sitagliptin synthesis avoiding DMF and chromatography. Discover cost-effective manufacturing and high-purity supply solutions.